Volume 11, Issue 6 pp. 647-655
ORIGINAL ARTICLE

Transcatheter Patent Ductus Arteriosus Occlusion in Small Infants

Matthew C. Schwartz MD

Corresponding Author

Matthew C. Schwartz MD

The Heart Center, Arnold Palmer Hospital for Children, Orlando, Fla, USA

College of Medicine, University of Central Florida, Orlando, Fla, USA

Corresponding Author: Matthew C. Schwartz, MD, The Heart Center, Arnold Palmer Hospital for Children, 92 West Miller Street, Orlando, FL 32806, USA. Tel: 407-649-6907; Fax: 407-481-2035; E-mail: [email protected]Search for more papers by this author
David Nykanen MD

David Nykanen MD

The Heart Center, Arnold Palmer Hospital for Children, Orlando, Fla, USA

College of Medicine, University of Central Florida, Orlando, Fla, USA

Search for more papers by this author
Lawrence H. Winner PhD

Lawrence H. Winner PhD

Department of Statistics, University of Florida, Gainesville, Fla, USA

Search for more papers by this author
Jose Perez MD

Jose Perez MD

Division of Neonatology, Winnie Palmer Hospital, Orlando, Fla, USA

Search for more papers by this author
Michael McMahan MD

Michael McMahan MD

Division of Neonatology, Winnie Palmer Hospital, Orlando, Fla, USA

Search for more papers by this author
Hamish M. Munro MD, FRCA

Hamish M. Munro MD, FRCA

Division of Cardiac Anesthesiology, Arnold Palmer Hospital for Children, Orlando, Fla, USA

Search for more papers by this author
Sukumar Suguna Narasimhulu MD

Sukumar Suguna Narasimhulu MD

College of Medicine, University of Central Florida, Orlando, Fla, USA

Division of Cardiac Intensive Care, Arnold Palmer Hospital for Children, Orlando, Fla, USA

Search for more papers by this author
First published: 26 May 2016
Citations: 9

Conflict of interest: The authors have no financial relationships or conflicts of interest to disclose.

Abstract

Background

Transcatheter patent ductus arteriosus (PDA) occlusion is feasible in small infants and may improve lung function in symptomatic patients. We aimed to describe transcatheter PDA closure in small infants including predictors of technical success and rate of complication and to identify factors associated with improved respiratory status after closure.

Methods

All patients in the NICU at our center who were referred for transcatheter PDA occlusion between 1/2010 and 11/2014 were retrospectively identified. Relevant details were extracted. Additionally, a modification of the respiratory severity score (RSS) (FiO2 × mean airway pressure) was used to characterize degree of pulmonary support before and at intervals after catheterization.

Results

Twenty patients were identified with median age of 96 days (13–247) and weight of 3.1 kg (1.7–4.7). The PDA was type F morphology in 14 (70%) patients. The PDA was successfully occluded in 16 (80%) patients. Ratio of minimum PDA diameter/length was >0.5 in all unsuccessful attempts and <0.4 in all successful cases (P = .01). Of the 16 cases of occlusion, Amplatzer Vascular Plug II was used in 15 (94%). No deaths or pulse loss occurred. Five (25%) patients required blood transfusion and transfusion was associated with lower hemoglobin (P = .049), lower weight (P = .008), and lower aortic pressure (P = .04). Excluding 1 patient with significant congenital heart disease, the RSS improved at 3 days in 9 (60%) patients and at 7 days in 12 (80%) compared with preintervention value. Patient factors were not associated with improved RSS at 3 or 7 days.

Conclusions

In our cohort of symptomatic infants, transcatheter PDA occlusion was successful in most and a ratio of minimum PDA diameter/length of <0.4 was predictive of technical success. Using a surrogate for pulmonary support, the majority of patients were on less support 7 days after closure.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.